Author Archives: bsmcconnell

News

Ascletis Gains Exclusive China Market Rights from Presidio to Clinical Stage Hepatitis C Virus (HCV) NS5A Inhibitor PPI-668 Hangzhou, China, Research Triangle Park, NC and San Francisco, CA – November 10, 2014 – Ascletis and Presidio announced today that they … Continue reading

Posted in Uncategorized